F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Chronic hepatitis B

Page 1 of 4 ( 191 items )
<<
1
2
3
4
>>

1	Risk factors and predictive model for hepatitis B virus deoxyribonucleic acid elevation in mid-to-late pregnancy with low viremia 10/21/2026 2:09:39 AM \| Browse: 38 \| Download: 78
2	Pegylated interferon α-2b add-on to nucleos(t)ide analogues reduces hepatocellular carcinoma and decompensation in advanced fibrotic chronic hepatitis B 10/15/2026 5:45:55 AM \| Browse: 54 \| Download: 126
3	From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B 9/17/2026 5:48:20 AM \| Browse: 47 \| Download: 95
4	Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration 9/7/2026 2:26:33 AM \| Browse: 75 \| Download: 108
5	Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B 9/1/2026 6:22:40 AM \| Browse: 47 \| Download: 96
6	Routine laboratory model for identifying significant fibrosis in chronic hepatitis B 6/26/2026 9:50:21 AM \| Browse: 71 \| Download: 350
7	Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines 6/26/2026 9:50:19 AM \| Browse: 57 \| Download: 283
8	Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B 6/18/2026 7:52:55 AM \| Browse: 72 \| Download: 319
9	Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B 5/29/2026 7:26:46 AM \| Browse: 72 \| Download: 428
10	Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology 5/26/2026 3:52:09 AM \| Browse: 54 \| Download: 258
11	Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study 5/26/2026 3:52:08 AM \| Browse: 79 \| Download: 389
12	Why does hepatitis B remain underprioritized? A view through lived experience 4/23/2026 11:05:50 AM \| Browse: 122 \| Download: 370
13	Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study 3/19/2026 7:07:29 AM \| Browse: 115 \| Download: 423
14	Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation 2/12/2026 11:20:21 AM \| Browse: 162 \| Download: 645
15	Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B 2/12/2026 11:20:19 AM \| Browse: 162 \| Download: 633
16	Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey 12/25/2025 9:13:55 AM \| Browse: 136 \| Download: 587
17	Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B 11/28/2025 3:10:38 AM \| Browse: 329 \| Download: 689
18	Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B 11/4/2025 2:41:47 AM \| Browse: 339 \| Download: 816
19	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 465 \| Download: 640
20	Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B 10/24/2025 7:36:34 AM \| Browse: 389 \| Download: 608
21	Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B 10/24/2025 7:36:26 AM \| Browse: 234 \| Download: 481
22	Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies 9/26/2025 8:18:47 AM \| Browse: 599 \| Download: 596
23	Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report 9/25/2025 11:24:05 AM \| Browse: 209 \| Download: 613
24	Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years 9/25/2025 11:24:00 AM \| Browse: 458 \| Download: 590
25	Chronic hepatitis B: Is it time for expanded antiviral treatment? 9/25/2025 9:22:03 AM \| Browse: 306 \| Download: 451
26	Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics 7/25/2025 12:09:41 PM \| Browse: 332 \| Download: 738
27	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 339 \| Download: 1076
28	Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B 7/4/2025 9:23:52 AM \| Browse: 238 \| Download: 1008
29	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 402 \| Download: 1233
30	Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease 5/27/2025 7:04:47 AM \| Browse: 356 \| Download: 1009
31	Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients 3/13/2025 10:11:05 AM \| Browse: 307 \| Download: 985
32	Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment 2/26/2025 4:21:35 AM \| Browse: 309 \| Download: 715
33	CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment 12/20/2024 3:53:46 AM \| Browse: 132 \| Download: 614
34	Current status of drug therapy for chronic hepatitis B 12/18/2024 7:36:02 AM \| Browse: 362 \| Download: 928
35	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 407 \| Download: 1143
36	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 409 \| Download: 1386
37	Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens 11/12/2024 6:08:07 AM \| Browse: 207 \| Download: 1250
38	Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action 11/6/2024 9:50:59 AM \| Browse: 342 \| Download: 1083
39	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 386 \| Download: 981
40	Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return 10/21/2024 7:03:25 AM \| Browse: 391 \| Download: 882
41	Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered 7/26/2024 10:33:30 AM \| Browse: 419 \| Download: 1266
42	Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis 7/26/2024 10:33:30 AM \| Browse: 473 \| Download: 1830
43	Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients 7/9/2024 2:00:35 PM \| Browse: 331 \| Download: 852
44	Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors 6/25/2024 10:41:21 AM \| Browse: 443 \| Download: 852
45	Hepatitis B cure: Current situation and prospects 6/20/2024 3:42:22 AM \| Browse: 397 \| Download: 1087
46	Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase 6/20/2024 3:42:22 AM \| Browse: 263 \| Download: 1457
47	Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy 3/27/2024 1:28:19 PM \| Browse: 431 \| Download: 1563
48	Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study 3/11/2024 2:44:49 PM \| Browse: 551 \| Download: 1603
49	Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis 3/6/2024 6:10:52 AM \| Browse: 526 \| Download: 1409
50	Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study 2/4/2024 10:57:42 AM \| Browse: 591 \| Download: 1869

Page 1 of 4 ( 191 items )
<<
1
2
3
4
>>

1	Risk factors and predictive model for hepatitis B virus deoxyribonucleic acid elevation in mid-to-late pregnancy with low viremia 10/21/2026 2:09:39 AM \| Browse: 38 \| Download: 78
2	Pegylated interferon α-2b add-on to nucleos(t)ide analogues reduces hepatocellular carcinoma and decompensation in advanced fibrotic chronic hepatitis B 10/15/2026 5:45:55 AM \| Browse: 54 \| Download: 126
3	From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B 9/17/2026 5:48:20 AM \| Browse: 47 \| Download: 95
4	Biological interpretation of baseline hepatitis B surface antigen and cirrhosis in determining interferon treatment duration 9/7/2026 2:26:33 AM \| Browse: 75 \| Download: 108
5	Predictive model to identify patients requiring extended interferon therapy in chronic hepatitis B 9/1/2026 6:22:40 AM \| Browse: 47 \| Download: 96
6	Routine laboratory model for identifying significant fibrosis in chronic hepatitis B 6/26/2026 9:50:21 AM \| Browse: 71 \| Download: 350
7	Comparing validated hepatocellular carcinoma risk scores for chronic hepatitis B against current Australian surveillance guidelines 6/26/2026 9:50:19 AM \| Browse: 57 \| Download: 283
8	Letter to the Editor: Physical functioning as a neglected determinant of antiviral adherence in chronic hepatitis B 6/18/2026 7:52:55 AM \| Browse: 72 \| Download: 319
9	Bone and renal safety of initial antiviral therapy using tenofovir alafenamide fumarate or entecavir for chronic hepatitis B 5/29/2026 7:26:46 AM \| Browse: 72 \| Download: 428
10	Beyond fibrosis: The imperative for dual steatosis and fibrosis assessment in chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease co-pathology 5/26/2026 3:52:09 AM \| Browse: 54 \| Download: 258
11	Diagnostic efficacy and influencing factors of non-invasive liver fibrosis scores in chronic hepatitis B fibrosis: Cross-sectional study 5/26/2026 3:52:08 AM \| Browse: 79 \| Download: 389
12	Why does hepatitis B remain underprioritized? A view through lived experience 4/23/2026 11:05:50 AM \| Browse: 122 \| Download: 370
13	Baseline hepatitis B surface antigen and cirrhosis predict extended interferon therapy in chronic hepatitis B: A retrospective study 3/19/2026 7:07:29 AM \| Browse: 115 \| Download: 423
14	Predictive tool for evident histological liver injury in chronic hepatitis B patients: Development and validation 2/12/2026 11:20:21 AM \| Browse: 162 \| Download: 645
15	Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B 2/12/2026 11:20:19 AM \| Browse: 162 \| Download: 633
16	Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey 12/25/2025 9:13:55 AM \| Browse: 136 \| Download: 587
17	Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B 11/28/2025 3:10:38 AM \| Browse: 329 \| Download: 689
18	Meta-analysis of factors associated with the incidence of comorbid depression and anxiety in patients with chronic hepatitis B 11/4/2025 2:41:47 AM \| Browse: 339 \| Download: 816
19	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 465 \| Download: 640
20	Association of serum hepatitis B surface antigen with hepatitis B virus DNA and hepatic function in patients with chronic hepatitis B 10/24/2025 7:36:34 AM \| Browse: 389 \| Download: 608
21	Association between hepatitis B virus markers and liver fibrosis staging in patients with chronic hepatitis B 10/24/2025 7:36:26 AM \| Browse: 234 \| Download: 481
22	Psychological distress and treatment adherence-challenges of patients with chronic hepatitis B: Risk factors and integrated nursing strategies 9/26/2025 8:18:47 AM \| Browse: 599 \| Download: 596
23	Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report 9/25/2025 11:24:05 AM \| Browse: 209 \| Download: 613
24	Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years 9/25/2025 11:24:00 AM \| Browse: 458 \| Download: 590
25	Chronic hepatitis B: Is it time for expanded antiviral treatment? 9/25/2025 9:22:03 AM \| Browse: 306 \| Download: 451
26	Advancing therapeutic vaccines for chronic hepatitis B: Integrating reverse vaccinology and immunoinformatics 7/25/2025 12:09:41 PM \| Browse: 332 \| Download: 738
27	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 339 \| Download: 1076
28	Rate of abnormal renal function index and related risk factors in patients with chronic hepatitis B 7/4/2025 9:23:52 AM \| Browse: 238 \| Download: 1008
29	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 402 \| Download: 1233
30	Microbial characteristics of gut microbiome dysbiosis in patients with chronic liver disease 5/27/2025 7:04:47 AM \| Browse: 356 \| Download: 1009
31	Attenuation imaging: Diagnostic differences in hepatic steatosis for chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease patients 3/13/2025 10:11:05 AM \| Browse: 307 \| Download: 985
32	Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment 2/26/2025 4:21:35 AM \| Browse: 309 \| Download: 715
33	CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment 12/20/2024 3:53:46 AM \| Browse: 132 \| Download: 614
34	Current status of drug therapy for chronic hepatitis B 12/18/2024 7:36:02 AM \| Browse: 362 \| Download: 928
35	Revolutionizing the understanding of liver disease: Metabolism, function and future 11/29/2024 2:50:19 PM \| Browse: 407 \| Download: 1143
36	Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus 11/29/2024 2:50:18 PM \| Browse: 409 \| Download: 1386
37	Recurrence and influencing factors of hepatitis B surface antigen seroclearance induced by peginterferon alpha-based regimens 11/12/2024 6:08:07 AM \| Browse: 207 \| Download: 1250
38	Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action 11/6/2024 9:50:59 AM \| Browse: 342 \| Download: 1083
39	Portocaval shunts' role in gut microbiota and hepatic encephalopathy: The gut-to-brain pathway 10/31/2024 10:42:49 AM \| Browse: 386 \| Download: 981
40	Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return 10/21/2024 7:03:25 AM \| Browse: 391 \| Download: 882
41	Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered 7/26/2024 10:33:30 AM \| Browse: 419 \| Download: 1266
42	Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis 7/26/2024 10:33:30 AM \| Browse: 473 \| Download: 1830
43	Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients 7/9/2024 2:00:35 PM \| Browse: 331 \| Download: 852
44	Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase-inhibitors 6/25/2024 10:41:21 AM \| Browse: 443 \| Download: 852
45	Hepatitis B cure: Current situation and prospects 6/20/2024 3:42:22 AM \| Browse: 397 \| Download: 1087
46	Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase 6/20/2024 3:42:22 AM \| Browse: 263 \| Download: 1457
47	Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy 3/27/2024 1:28:19 PM \| Browse: 431 \| Download: 1563
48	Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study 3/11/2024 2:44:49 PM \| Browse: 551 \| Download: 1603
49	Risk of hepatitis B virus reactivation in oncological patients treated with tyrosine kinase inhibitors: A case report and literature analysis 3/6/2024 6:10:52 AM \| Browse: 526 \| Download: 1409
50	Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study 2/4/2024 10:57:42 AM \| Browse: 591 \| Download: 1869